Literature DB >> 28260789

HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

M Terol1, H Gazon1,2, I Lemasson3, M Duc-Dodon4, B Barbeau5, R Césaire6, J-M Mesnard1, J-M Péloponèse1.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) basic-leucine zipper (bZIP) factor (HBZ) is a key player in proliferation and transformation of HTLV-1-infected cells, thus contributing to adult T-cell leukemia (ATL) development. HBZ deregulates gene expression within the host cell by interacting with several cellular partners. Through its C-terminal ZIP domain, HBZ is able to contact and activate JunD, a transcription factor of the AP-1 family. JunD mRNA is intronless but can generate two protein isoforms by alternative translation initiation: JunD full-length and Δ JunD, an N-terminal truncated form unresponsive to the tumor suppressor menin. Using various cell lines and primary T-lymphocytes, we show that after serum deprivation HBZ induces the expression of Δ JunD isoform. We demonstrate that, unlike JunD, Δ JunD induces proliferation and transformation of cells. To decipher the mechanisms for Δ JunD production, we looked into the translational machinery and observed that HBZ induces nuclear retention of RPS25 mRNA and loss of RPS25 protein expression, a component of the small ribosomal subunit. Therefore, HBZ bypasses translational control of JunD uORF and favors the expression of Δ JunD. In conclusion, we provide strong evidences that HBZ induces Δ JunD expression through alteration of the cellular translational machinery and that the truncated isoform Δ JunD has a central role in the oncogenic process leading to ATL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28260789     DOI: 10.1038/leu.2017.74

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  60 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop.

Authors:  X Zhang; W Wang; H Wang; M-H Wang; W Xu; R Zhang
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

Review 3.  Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation.

Authors:  Jean-Marie Peloponese; Man Lung Yeung; Kuan-Teh Jeang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras.

Authors:  C M Pfarr; F Mechta; G Spyrou; D Lallemand; S Carillo; M Yaniv
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

Review 5.  Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?

Authors:  Benoit Barbeau; Jean-Michel Mesnard
Journal:  Int Rev Immunol       Date:  2007 Sep-Dec       Impact factor: 5.311

6.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

7.  Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays.

Authors:  Aaron W Reinke; Gevorg Grigoryan; Amy E Keating
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

Review 8.  Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs).

Authors:  Benoit Barbeau; Jean-Michel Mesnard
Journal:  Viruses       Date:  2011-05-05       Impact factor: 5.048

9.  HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).

Authors:  Anne-Sophie Kuhlmann; Julien Villaudy; Louis Gazzolo; Marc Castellazzi; Jean-Michel Mesnard; Madeleine Duc Dodon
Journal:  Retrovirology       Date:  2007-12-13       Impact factor: 4.602

10.  Discovery of adult T-cell leukemia.

Authors:  Kiyoshi Takatsuki
Journal:  Retrovirology       Date:  2005-03-02       Impact factor: 4.602

View more
  8 in total

1.  Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.

Authors:  Alain Chebly; Joana Ropio; Jean-Marie Peloponese; Sandrine Poglio; Martina Prochazkova-Carlotti; Floriane Cherrier; Jacky Ferrer; Yamina Idrissi; Evelyne Segal-Bendirdjian; Eliane Chouery; Chantal Farra; Anne Pham-Ledard; Marie Beylot-Barry; Jean-Philippe Merlio; Roland Tomb; Edith Chevret
Journal:  Mol Oncol       Date:  2021-10-12       Impact factor: 7.449

Review 2.  The SUMO Pathway in Hematomalignancies and Their Response to Therapies.

Authors:  Mathias Boulanger; Rosa Paolillo; Marc Piechaczyk; Guillaume Bossis
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

3.  Collagen IV (COL4A1, COL4A2), a Component of the Viral Biofilm, Is Induced by the HTLV-1 Oncoprotein Tax and Impacts Virus Transmission.

Authors:  Sebastian Millen; Christine Gross; Norbert Donhauser; Melanie C Mann; Jean-Marie Péloponèse; Andrea K Thoma-Kress
Journal:  Front Microbiol       Date:  2019-10-23       Impact factor: 5.640

Review 4.  HTLV-1 bZIP factor: the key viral gene for pathogenesis.

Authors:  Masao Matsuoka; Jean-Michel Mesnard
Journal:  Retrovirology       Date:  2020-01-08       Impact factor: 4.602

Review 5.  Alternative RNA splicing in cancer: what about adult T-cell leukemia?

Authors:  Julie Tram; Jean-Michel Mesnard; Jean-Marie Peloponese
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 6.  Hijacking of the AP-1 Signaling Pathway during Development of ATL.

Authors:  Hélène Gazon; Benoit Barbeau; Jean-Michel Mesnard; Jean-Marie Peloponese
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

Review 7.  HTLV-1 Alters T Cells for Viral Persistence and Transmission.

Authors:  Azusa Tanaka; Masao Matsuoka
Journal:  Front Microbiol       Date:  2018-03-20       Impact factor: 5.640

Review 8.  Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.

Authors:  Robert Harrod
Journal:  Retrovirology       Date:  2019-09-06       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.